Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% Minoxidil Foam for Male Androgenetic Alopecia
NCT00151515Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in androgenetic alopecia (AGA) comparing 5% Minoxidil Foam with Placebo Foam (2 arms). Primary endpoints: Mean change in non-vellus hair count in the target region at 16 weeks and Subject rating of overall improvement at 16 weeks. Started Oct 2003; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT00151515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151515.